XML 45 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Net Loss Per Share - Shares Excluded From Computation Of Diluted Net Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Apr. 30, 2019
Mar. 31, 2019
Apr. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Total common stock equivalents (in shares) 12,989 10,058 8,828 11,379        
0.25% Convertible Senior Notes Due 2023 | Senior Notes                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Face value $ 173,018,000   $ 173,018,000   $ 345,000,000     $ 345,000,000
Conversion price $ 26.95   $ 26.95          
0.25% Convertible Senior Notes Due 2023 | Senior Notes | Capped Call                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Conversion price $ 40.68   $ 40.68          
0.125% Convertible Senior Notes Due 2025 | Senior Notes                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Face value $ 800,000,000   $ 800,000,000   $ 800,000,000 $ 100,000,000 $ 700,000,000  
Conversion price $ 51.56   $ 51.56          
0.125% Convertible Senior Notes Due 2025 | Senior Notes | Capped Call                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Conversion price $ 79.32   $ 79.32          
Options to purchase common stock                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Total common stock equivalents (in shares) 865 2,122 977 2,715        
RSUs and PSUs                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Total common stock equivalents (in shares) 3,394 3,831 3,425 4,952        
Senior Notes                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Total common stock equivalents (in shares) 8,721 4,098 4,422 3,709        
Employee stock purchase plan                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Total common stock equivalents (in shares) 9 7 4 3